Aurobindo Pharma calls off $1 billion deal with Sandoz after failing to get FTC nod – Livemint
MUMBAI : Hyderabad based generic drug maker Aurobindo Pharma Ltd on Thursday said that it is calling off its proposed acquisition of the US dermatology business and three manufacturing units of San…
